Adding
Therapeutic
Value

By Designing Safe Hits-Leads For Small Molecules.

The Preclinical stage is all about strategy and competitors. In your pipeline, you are used to processing and analysing large volumes of data.

As you know, you also need to react quickly to unexpected business events. Have you ever considered embracing polypharmacology?

Characterizing Full Potential Of Preclinical Small Molecules

  • Target hopping: Identification of polypharmacology-based profile of hits/leads biological targets, investigation of Mechanism of Action (MOA) and pathways
  • Scaffold hopping: lead identification in a drug discovery project (starting with a safe drug)
  • Manage toxicity by proposing novel safe drug candidat

Preclinical stage